Developmental and degenerative features in a complicated spastic paraplegia

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Troyer syndrome is a complicated hereditary spastic paraplegia (HSP) previously thought to be exclusive to the Amish population.
• The SPG20 gene has been implicated in the pathogenesis of Troyer syndrome.

Purpose of the Study:

• To investigate the genetic and molecular underpinnings of Troyer syndrome.
• To identify novel mutations in the SPG20 gene and analyze its expression patterns.
• To determine if Troyer syndrome occurs in non-Amish populations.

Main Methods:

• Clinical assessment of two Omani families presenting with Troyer syndrome features.
• Linkage analysis and SPG20 gene sequencing.
• Quantitative PCR and in situ hybridization to analyze SPG20 gene expression in human and mouse tissues during development.

Main Results:

• Two Omani families with Troyer syndrome were identified, exhibiting core features like short stature, dysarthria, and developmental delay.
• A novel mutation in the SPG20 gene was discovered in these Omani families, similar to mutations found in Amish patients.
• SPG20 gene expression is widespread but notably high in limb buds and the forebrain during early embryonic development, with lower levels in the adult brain.

Conclusions:

• SPG20 gene mutations are the cause of Troyer syndrome, a condition characterized by both developmental and degenerative neurological deficits.
• The specific expression pattern of SPG20 during embryogenesis, particularly in limb buds and the forebrain, likely explains the skeletal and cognitive abnormalities seen in Troyer syndrome.